ANI Pharmaceuticals, Inc.
US ˙ NasdaqGM ˙ US00182C1036

SecurityANIP / ANI Pharmaceuticals, Inc.
InstitutionDimensional Fund Advisors Lp
Latest Disclosed Ownership531,190 shares
Latest Disclosed Value $ 40,842,741
Dimensional Fund Advisors Lp reports 8.92% increase in ownership of ANIP / ANI Pharmaceuticals, Inc.

On May 7, 2026 - Dimensional Fund Advisors Lp filed a 13F-HR form disclosing ownership of 531,190 shares of ANI Pharmaceuticals, Inc. (US:ANIP) valued at $40,848,511 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 12, 2026 disclosing 487,667 shares of ANI Pharmaceuticals, Inc.. This represents a change in shares of 8.92% during the quarter. The current value of the position is $43,084,821 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-07 2026-03-31 13F ANI PHARMACEUTICALS COM 00182C103 531,190 43,523 8.92 40,843 6.09 0.0018
2026-02-12 2025-12-31 13F ANI PHARMACEUTICALS COM 00182C103 487,667 -17,761 -3.51 38,497 -16.85 0.0081
2025-11-12 2025-09-30 13F ANI PHARMACEUTICALS COM 00182C103 505,428 -48,465 -8.75 46,298 28.10 0.0099
2025-08-12 2025-06-30 13F ANI PHARMACEUTICALS COM 00182C103 553,893 -77,668 -12.30 36,142 -14.52 0.0084
2025-05-13 2025-03-31 13F ANI PHARMACEUTICALS COM 00182C103 631,561 -54,169 -7.90 42,283 11.55 0.0105
2025-02-13 2024-12-31 13F ANI PHARMACEUTICALS COM 00182C103 685,730 30,420 4.64 37,906 -3.04 0.0091
2024-11-07 2024-09-30 13F ANI PHARMACEUTICALS COM 00182C103 655,310 25,084 3.98 39,095 -2.59 0.0095
2024-08-09 2024-06-30 13F ANI PHARMACEUTICALS COM 00182C103 630,226 21,053 3.46 40,132 -4.70 0.0105
2024-05-10 2024-03-31 13F ANI PHARMACEUTICALS COM 00182C103 609,173 17,442 2.95 42,112 29.07 0.0114
2024-02-07 2023-12-31 13F ANI PHARMACEUTICALS COM 00182C103 591,731 33,359 5.97 32,628 0.64 0.0095
2023-11-09 2023-09-30 13F ANI PHARMACEUTICALS COM 00182C103 558,372 14,430 2.65 32,420 10.72 0.0106
2023-08-09 2023-06-30 13F ANI PHARMACEUTICALS COM 00182C103 543,942 12,750 2.40 29,280 38.78 0.0093
2023-05-12 2023-03-31 13F ANI PHARMACEUTICALS COM 00182C103 531,192 4,116 0.78 21,099 100,366.67 0.0071
2023-02-09 2022-12-31 13F ANI PHARMACEUTICALS COM 00182C103 527,076 1,627 0.31 21 -99.88 0.0063
2022-11-10 2022-09-30 13F ANI PHARMACEUTICALS COM 00182C103 525,449 -13,294 -2.47 16,887 5.66 0.0065
2022-08-12 2022-06-30 13F ANI PHARMACEUTICALS COM 00182C103 538,743 82,596 18.11 15,983 24.64 0.0057
2022-05-13 2022-03-31 13F ANI PHARMACEUTICALS COM 00182C103 456,147 66,843 17.17 12,823 -28.52 0.0040
2022-02-09 2021-12-31 13F ANI PHARMACEUTICALS COM 00182C103 389,304 11,088 2.93 17,940 44.51 0.0054
2021-11-12 2021-09-30 13F ANI PHARMACEUTICALS COM 00182C103 378,216 -60,960 -13.88 12,414 -19.35 0.0040
2021-08-12 2021-06-30 13F ANI PHARMACEUTICALS COM 00182C103 439,176 30,862 7.56 15,392 4.47 0.0049
2021-05-14 2021-03-31 13F ANI PHARMACEUTICALS COM 00182C103 408,314 -19,340 -4.52 14,734 18.64 0.0049
2021-03-08 2020-12-31 13F/A-2 ANI PHARMACEUTICALS COM 00182C103 427,654 -15,118 -3.41 12,419 -0.58 0.0045
2021-02-11 2020-12-31 13F ANI PHARMACEUTICALS COM 00182C103 427,654 -15,118 12,419 4,485.0827
2020-11-12 2020-09-30 13F ANI PHARMACEUTICALS COM 00182C103 442,772 -52,891 -10.67 12,491 -22.07 0.0053
2020-08-13 2020-06-30 13F ANI PHARMACEUTICALS COM 00182C103 495,663 -6,496 -1.29 16,029 -21.65 0.0070
2020-05-14 2020-03-31 13F ANI PHARMACEUTICALS COM 00182C103 502,159 -18,712 -3.59 20,458 -36.31 0.0107
2020-02-14 2019-12-31 13F ANI PHARMACEUTICALS COM 00182C103 520,871 -15,069 -2.81 32,122 -17.76 0.0117
2019-11-12 2019-09-30 13F ANI PHARMACEUTICALS COM 00182C103 535,940 -1,487 -0.28 39,059 -11.58 0.0152
2019-08-13 2019-06-30 13F ANI PHARMACEUTICALS COM 00182C103 537,427 2,434 0.45 44,175 17.06 0.0172
2019-08-12 2019-03-31 13F/A-2 ANI PHARMACEUTICALS COM 00182C103 534,993 16,566 3.20 37,737 61.69 0.0150
2019-05-10 2019-03-31 13F ANI PHARMACEUTICALS COM 00182C103 534,993 16,566 37,737
2019-02-26 2018-12-31 13F/A-1 ANI PHARMACEUTICALS COM 00182C103 518,427 6,546 1.28 23,339 -19.36 0.0106
2019-02-13 2018-12-31 13F ANI PHARMACEUTICALS COM 00182C103 518,427 6,546 23,339
2018-11-13 2018-09-30 13F ANI PHARMACEUTICALS COM 00182C103 511,881 32,556 6.79 28,941 -9.61 0.0110
2018-08-10 2018-06-30 13F ANI PHARMACEUTICALS COM 00182C103 479,325 11,081 2.37 32,019 17.45 0.0128
2018-05-11 2018-03-31 13F ANI PHARMACEUTICALS COM 00182C103 468,244 12,427 2.73 27,261 -7.20 0.0114
2018-02-12 2017-12-31 13F ANI PHARMACEUTICALS COM 00182C103 455,817 31,020 7.30 29,377 31.75 0.0122
2017-11-13 2017-09-30 13F ANI PHARMACEUTICALS COM 00182C103 424,797 85,529 25.21 22,297 40.43 0.0097
2017-08-11 2017-06-30 13F ANI PHARMACEUTICALS COM 00182C103 339,268 161,743 91.11 15,878 80.66 0.0073
2017-05-12 2017-03-31 13F ANI PHARMACEUTICALS COM 00182C103 177,525 86,011 93.99 8,789 58.42 0.0042
2017-02-09 2016-12-31 13F ANI PHARMACEUTICALS COM 00182C103 91,514 43,534 90.73 5,548 74.30 0.0028
2016-11-10 2016-09-30 13F ANI PHARMACEUTICALS COM 00182C103 47,980 33,654 234.92 3,183 297.88 0.0017
2016-08-09 2016-06-30 13F ANI PHARMACEUTICALS COM 00182C103 14,326 403 2.89 800 70.58 0.0005
2016-05-13 2016-03-31 13F ANI PHARMACEUTICALS COM 00182C103 13,923 0 0.00 469 -25.32 0.0003
2016-02-10 2015-12-31 13F ANI PHARMACEUTICALS COM 00182C103 13,923 0 0.00 628 14.18 0.0004
2015-11-13 2015-09-30 13F ANI PHARMACEUTICALS COM 00182C103 13,923 0 0.00 550 -36.34 0.0004
2015-08-14 2015-06-30 13F ANI PHARMACEUTICALS COM 00182C103 13,923 8,440 153.93 864 151.90 0.0005
2015-05-14 2015-03-31 13F ANI PHARMACEUTICALS COM 00182C103 5,483 0 0.00 343 11.00 0.0002
2015-02-06 2014-12-31 13F ANI PHARMACEUTICALS COM 00182C103 5,483 -4,047 -42.47 309 14.44 0.0002
2014-11-13 2014-09-30 13F ANI PHARMACEUTICALS COM 00182C103 9,530 0 0.00 270 -17.68 0.0002
2014-08-08 2014-06-30 13F ANI PHARMACEUTICALS COM 00182C103 9,530 -175 -1.80 328 7.89 0.0002
2014-05-14 2014-03-31 13F ANI PHARMACEUTICALS COM 00182C103 9,705 0 0.00 304 55.90 0.0002
2014-02-12 2013-12-31 13F ANI PHARMACEUTICALS COM 00182C103 9,705 0 0.00 195 105.26 0.0002
2013-11-13 2013-09-30 13F ANI PHARMACEUTICALS COM 00182C103 9,705 9,705 95 0.0001
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.